Akr7a3 Rat 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of AKR7A3 mRNA CTD PMID:21983209 Akr7a3 Rat 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of AKR7A3 mRNA CTD PMID:17108234 Akr7a3 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of AKR7A3 mRNA CTD PMID:32145629 Akr7a3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR7A3 mRNA CTD PMID:21215274 Akr7a3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR7A3 mRNA CTD PMID:16054898 more ... Akr7a3 Rat 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 Akr7a3 Rat 2,4-diaminotoluene increases expression EXP 6480464 2 and 4-diaminotoluene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 Akr7a3 Rat 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of AKR7A3 protein CTD PMID:8198522 Akr7a3 Rat 2,6-di-tert-butyl-4-methylphenol increases activity EXP 6480464 Butylated Hydroxytoluene results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat 2,6-diaminotoluene decreases expression EXP 6480464 2 and 6-diaminotoluene results in decreased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 Akr7a3 Rat 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one increases expression EXP 6480464 Praziquantel results in increased expression of AKR7A3 mRNA CTD PMID:21813463 Akr7a3 Rat 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 Akr7a3 Rat 2-nitro-p-phenylenediamine increases expression EXP 6480464 2-nitro-4-phenylenediamine results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of AKR7A3 mRNA CTD PMID:14600272 more ... Akr7a3 Rat 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 2-palmitoylglycerol increases expression ISO AKR7A3 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AKR7A3 mRNA CTD PMID:37199045 Akr7a3 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 Akr7a3 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of AKR7A3 protein CTD PMID:34915118 Akr7a3 Rat 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 more ... CTD PMID:19162173 more ... Akr7a3 Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of AKR7A3 mRNA CTD PMID:14600272 and PMID:23052194 Akr7a3 Rat 4-acetylaminofluorene increases expression EXP 6480464 4-acetylaminofluorene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of AKR7A3 mRNA CTD PMID:21346803 Akr7a3 Rat 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1 and 2-diamino-4-nitrobenzene results in increased expression of AKR7A3 mRNA CTD PMID:17070881 Akr7a3 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22687989 Akr7a3 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of AKR7A3 mRNA CTD PMID:30047161 Akr7a3 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of AKR7A3 mRNA CTD PMID:24780913 and PMID:25825206 Akr7a3 Rat 9,10-phenanthroquinone increases reduction EXP 6480464 AKR7A3 protein results in increased reduction of 9 and 10-phenanthrenequinone CTD PMID:19168568 Akr7a3 Rat 9,10-phenanthroquinone multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 AKR7A3 protein results in increased reduction of and affects the activity of 9 and 10-phenanthrenequinone CTD PMID:21910479 Akr7a3 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of AKR7A3 mRNA CTD PMID:31881176 Akr7a3 Rat acrolein affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of Acrolein CTD PMID:15019089 Akr7a3 Rat acrolein decreases response to substance EXP 6480464 AKR7A3 protein results in decreased susceptibility to Acrolein CTD PMID:15019089 Akr7a3 Rat aflatoxin B1 affects expression ISO AKR7A3 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of AKR7A3 protein CTD PMID:20106945 Akr7a3 Rat aflatoxin B1 decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of AKR7A3 mRNA CTD PMID:27153756 Akr7a3 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of AKR7A3 mRNA CTD PMID:14600272 more ... Akr7a3 Rat aflatoxin B1 decreases response to substance EXP 6480464 AKR7A3 protein results in decreased susceptibility to Aflatoxin B1 CTD PMID:8395332 Akr7a3 Rat aflatoxin B1 increases reduction EXP 6480464 AKR7A3 protein results in increased reduction of Aflatoxin B1 metabolite CTD PMID:19168568 Akr7a3 Rat aflatoxin B1 affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of Aflatoxin B1 CTD PMID:8395332 Akr7a3 Rat amiodarone affects expression EXP 6480464 Amiodarone affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AKR7A3 mRNA CTD PMID:16483693 Akr7a3 Rat antirheumatic drug increases expression ISO AKR7A3 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of AKR7A3 mRNA CTD PMID:24449571 Akr7a3 Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of AKR7A3 mRNA CTD PMID:23912714 Akr7a3 Rat aristolochic acid A increases expression ISO AKR7A3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of AKR7A3 mRNA CTD PMID:33212167 Akr7a3 Rat Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of AKR7A3 mRNA CTD PMID:18178546 Akr7a3 Rat arsenous acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR7A3 protein] CTD PMID:26598702 Akr7a3 Rat atazanavir sulfate multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 Akr7a3 Rat atazanavir sulfate decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 Akr7a3 Rat atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of AKR7A3 mRNA CTD PMID:36841081 Akr7a3 Rat benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat benzene affects expression EXP 6480464 Benzene affects the expression of AKR7A3 mRNA CTD PMID:15878777 Akr7a3 Rat benzo[a]pyrene decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of AKR7A3 mRNA CTD PMID:20106945 and PMID:32234424 Akr7a3 Rat benzo[a]pyrene affects methylation ISO AKR7A3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AKR7A3 promoter CTD PMID:27901495 Akr7a3 Rat benzo[a]pyrene-7,8-dione multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 and 8-dione CTD PMID:21910479 Akr7a3 Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA CTD PMID:18164116 Akr7a3 Rat beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of AKR7A3 mRNA CTD PMID:22687991 Akr7a3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AKR7A3 mRNA CTD PMID:25181051 and PMID:30903817 Akr7a3 Rat bisphenol A decreases expression ISO AKR7A3 (Homo sapiens) 6480464 bisphenol A results in decreased expression of AKR7A3 mRNA CTD PMID:31715268 Akr7a3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKR7A3 mRNA CTD PMID:30816183 more ... Akr7a3 Rat bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of AKR7A3 mRNA CTD PMID:12628495 more ... Akr7a3 Rat buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of AKR7A3 protein CTD PMID:8198522 Akr7a3 Rat cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A3 mRNA CTD PMID:29298499 Akr7a3 Rat cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of AKR7A3 mRNA CTD PMID:25993096 Akr7a3 Rat cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AKR7A3 mRNA CTD PMID:29298499 Akr7a3 Rat cafestol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 Akr7a3 Rat capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of AKR7A3 protein] CTD PMID:20359164 Akr7a3 Rat carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of AKR7A3 mRNA CTD PMID:17381134 Akr7a3 Rat chenodeoxycholic acid decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in decreased expression of AKR7A3 mRNA CTD PMID:27174168 Akr7a3 Rat chenodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Akr7a3 Rat chloroform increases expression EXP 6480464 Chloroform results in increased expression of AKR7A3 mRNA CTD PMID:21813463 Akr7a3 Rat chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 Akr7a3 Rat cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of AKR7A3 mRNA CTD PMID:18246545 more ... Akr7a3 Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of AKR7A3 mRNA CTD PMID:12011481 Akr7a3 Rat clofibrate affects expression EXP 6480464 Clofibrate affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of AKR7A3 mRNA and cobaltous chloride results in increased expression of AKR7A3 protein CTD PMID:24386269 Akr7a3 Rat cocaine affects expression EXP 6480464 Cocaine affects the expression of AKR7A3 mRNA CTD PMID:20187946 Akr7a3 Rat copper(II) sulfate decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of AKR7A3 mRNA CTD PMID:19549813 Akr7a3 Rat coumarin increases expression EXP 6480464 coumarin results in increased expression of AKR7A3 mRNA CTD PMID:18480146 Akr7a3 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of AKR7A3 mRNA CTD PMID:26577399 and PMID:27523638 Akr7a3 Rat cyclosporin A decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AKR7A3 mRNA CTD PMID:20106945 and PMID:25562108 Akr7a3 Rat cyclosporin A multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 Akr7a3 Rat deoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Akr7a3 Rat Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of AKR7A3 mRNA CTD PMID:19695238 Akr7a3 Rat diarsenic trioxide multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR7A3 protein] CTD PMID:26598702 Akr7a3 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of AKR7A3 mRNA CTD PMID:21266533 Akr7a3 Rat dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of AKR7A3 mRNA CTD PMID:21813463 Akr7a3 Rat diuron increases expression EXP 6480464 Diuron results in increased expression of AKR7A3 mRNA CTD PMID:25152437 Akr7a3 Rat emodin decreases activity ISO AKR7A3 (Homo sapiens) 6480464 Emodin results in decreased activity of AKR7A3 protein CTD PMID:35065925 Akr7a3 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of AKR7A3 mRNA CTD PMID:29391264 Akr7a3 Rat ethanol decreases expression ISO AKR7A3 (Homo sapiens) 6480464 Ethanol results in decreased expression of AKR7A3 protein CTD PMID:20621659 Akr7a3 Rat ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of AKR7A3 mRNA and Ethoxyquin results in increased expression of AKR7A3 protein CTD PMID:19695238 more ... Akr7a3 Rat ethoxyquin increases activity EXP 6480464 Ethoxyquin results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat etofenprox multiple interactions EXP 6480464 [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22467020 Akr7a3 Rat felbamate increases expression EXP 6480464 felbamate results in increased expression of AKR7A3 mRNA CTD PMID:17381134 Akr7a3 Rat finasteride increases expression EXP 6480464 Finasteride results in increased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of AKR7A3 mRNA CTD PMID:23962444 Akr7a3 Rat fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of AKR7A3 mRNA CTD PMID:16643972 Akr7a3 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of AKR7A3 mRNA CTD PMID:24793618 Akr7a3 Rat furan increases methylation EXP 6480464 furan results in increased methylation of AKR7A3 gene CTD PMID:22079235 Akr7a3 Rat furan increases expression EXP 6480464 furan results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... Akr7a3 Rat gabapentin increases expression EXP 6480464 gabapentin results in increased expression of AKR7A3 mRNA CTD PMID:17381134 Akr7a3 Rat gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of AKR7A3 mRNA CTD PMID:17785943 Akr7a3 Rat gemfibrozil affects expression EXP 6480464 Gemfibrozil affects the expression of AKR7A3 mRNA CTD PMID:12011481 Akr7a3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of AKR7A3 protein CTD PMID:21081137 and PMID:22061828 Akr7a3 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AKR7A3 mRNA CTD PMID:33387578 Akr7a3 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of AKR7A3 mRNA CTD PMID:15345336 and PMID:20621112 Akr7a3 Rat glycochenodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Akr7a3 Rat glycocholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Akr7a3 Rat glycodeoxycholic acid multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA more ... CTD PMID:32152650 and PMID:33819548 Akr7a3 Rat indole-3-methanol increases activity EXP 6480464 indole-3-carbinol results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22129741 Akr7a3 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of AKR7A3 mRNA CTD PMID:21396975 Akr7a3 Rat kahweol multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 Akr7a3 Rat L-ethionine affects expression EXP 6480464 Ethionine affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of AKR7A3 mRNA CTD PMID:22641619 Akr7a3 Rat melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA] CTD PMID:20033131 Akr7a3 Rat mercury atom multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 Akr7a3 Rat mercury dichloride multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 Akr7a3 Rat mercury(0) multiple interactions EXP 6480464 [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 mRNA and [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of AKR7A3 protein CTD PMID:29298499 Akr7a3 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... Akr7a3 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of AKR7A3 mRNA CTD PMID:30047161 Akr7a3 Rat methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 Akr7a3 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA more ... CTD PMID:18164116 more ... Akr7a3 Rat N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of AKR7A3 mRNA CTD PMID:19638242 and PMID:21813463 Akr7a3 Rat N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AKR7A3 mRNA CTD PMID:11323195 Akr7a3 Rat N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of AKR7A3 mRNA CTD PMID:14600272 Akr7a3 Rat N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of AKR7A3 mRNA and N-nitrosomorpholine results in increased expression of AKR7A3 protein CTD PMID:19716841 Akr7a3 Rat NADP zwitterion multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone more ... CTD PMID:21910479 Akr7a3 Rat NADP(+) multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [AKR7A3 protein co-treated with NADP] results in increased reduction of and affects the activity of 4-hydroxyequilenin-o-quinone more ... CTD PMID:21910479 Akr7a3 Rat naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of AKR7A3 mRNA CTD PMID:24976557 Akr7a3 Rat naphthalenes multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 AKR7A3 protein results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 Akr7a3 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat nefazodone decreases expression ISO AKR7A3 (Homo sapiens) 6480464 nefazodone results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 Akr7a3 Rat nefazodone multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of AKR7A3 mRNA CTD PMID:32152650 Akr7a3 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat O-methyleugenol decreases expression ISO AKR7A3 (Homo sapiens) 6480464 methyleugenol results in decreased expression of AKR7A3 mRNA CTD PMID:32234424 Akr7a3 Rat ochratoxin A multiple interactions EXP 6480464 [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of AKR7A3 protein] CTD PMID:17110534 Akr7a3 Rat ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of AKR7A3 mRNA and ochratoxin A results in decreased expression of AKR7A3 protein CTD PMID:16251485 and PMID:17110534 Akr7a3 Rat oltipraz increases activity EXP 6480464 oltipraz results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat omeprazole affects expression EXP 6480464 Omeprazole affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat omeprazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA CTD PMID:22687989 Akr7a3 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of AKR7A3 mRNA CTD PMID:23665939 Akr7a3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 Akr7a3 Rat oxfendazole multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA more ... CTD PMID:18754104 and PMID:20033131 Akr7a3 Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of AKR7A3 mRNA CTD PMID:27638505 Akr7a3 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of AKR7A3 mRNA CTD PMID:15120968 more ... Akr7a3 Rat paracetamol multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 Akr7a3 Rat perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of AKR7A3 mRNA CTD PMID:19162173 Akr7a3 Rat phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of AKR7A3 mRNA CTD PMID:17616710 Akr7a3 Rat phenethyl isothiocyanate increases activity EXP 6480464 phenethyl isothiocyanate results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AKR7A3 mRNA CTD PMID:12011481 more ... Akr7a3 Rat phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of AKR7A3 mRNA CTD PMID:17381134 Akr7a3 Rat phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of AKR7A3 mRNA CTD PMID:17381134 Akr7a3 Rat piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of AKR7A3 mRNA CTD PMID:18544911 and PMID:22484513 Akr7a3 Rat piperonyl butoxide multiple interactions EXP 6480464 Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of AKR7A3 mRNA] CTD PMID:18544911 Akr7a3 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of AKR7A3 mRNA CTD PMID:19162173 Akr7a3 Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AKR7A3 mRNA CTD PMID:12011481 Akr7a3 Rat pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of AKR7A3 mRNA CTD PMID:19162173 and PMID:30047161 Akr7a3 Rat propiconazole increases expression EXP 6480464 propiconazole results in increased expression of AKR7A3 mRNA CTD PMID:16643972 Akr7a3 Rat pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of AKR7A3 mRNA CTD PMID:22431067 Akr7a3 Rat quercetin affects expression EXP 6480464 Quercetin affects the expression of AKR7A3 mRNA CTD PMID:18178720 Akr7a3 Rat quercetin increases expression EXP 6480464 Quercetin results in increased expression of AKR7A3 mRNA CTD PMID:19191009 Akr7a3 Rat quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA CTD PMID:20033131 Akr7a3 Rat quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA CTD PMID:20033131 Akr7a3 Rat sinigrin increases activity EXP 6480464 sinigrin results in increased activity of AKR7A3 protein CTD PMID:9328168 Akr7a3 Rat sodium arsenite increases expression ISO AKR7A3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AKR7A3 mRNA CTD PMID:34032870 Akr7a3 Rat sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of AKR7A3 mRNA CTD PMID:25993096 Akr7a3 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of AKR7A3 mRNA CTD PMID:25905778 Akr7a3 Rat succinic semialdehyde affects metabolic processing EXP 6480464 AKR7A3 protein affects the metabolism of succinic semialdehyde CTD PMID:15019089 Akr7a3 Rat Sunset Yellow FCF multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 Akr7a3 Rat tartrazine multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 Akr7a3 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of AKR7A3 mRNA CTD PMID:31150632 Akr7a3 Rat thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of AKR7A3 mRNA CTD PMID:19483382 Akr7a3 Rat thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR7A3 mRNA CTD PMID:28943392 Akr7a3 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AKR7A3 mRNA CTD PMID:23411599 and PMID:34492290 Akr7a3 Rat toluene affects expression EXP 6480464 Toluene affects the expression of AKR7A3 mRNA CTD PMID:18653662 Akr7a3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 Akr7a3 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of AKR7A3 mRNA CTD PMID:25729387 Akr7a3 Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of AKR7A3 mRNA CTD PMID:16643972 Akr7a3 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of AKR7A3 mRNA CTD PMID:19448997 and PMID:33387578 Akr7a3 Rat triclosan multiple interactions ISO AKR7A3 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of AKR7A3 mRNA CTD PMID:33819548 Akr7a3 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of AKR7A3 mRNA CTD PMID:30589522 Akr7a3 Rat triphenyl phosphate affects expression ISO AKR7A3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of AKR7A3 mRNA CTD PMID:37042841 Akr7a3 Rat trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat umbelliferone increases expression ISO AKR7A3 (Homo sapiens) 6480464 7-hydroxycoumarin results in increased expression of AKR7A3 mRNA CTD PMID:28263721 Akr7a3 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of AKR7A3 mRNA CTD PMID:24136188 Akr7a3 Rat valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of AKR7A3 mRNA CTD PMID:17381134 and PMID:23665938